Citations for
1MAPK10, PPP2CB, RAC3
Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses
Sun S, Wang Y, Wang J, Bi J.
J Transl Med. Sep 27;19(1):409. doi: 10.1186/s12967-021-03061-4. 2021
2ARR3, MAPK10
Arrestin-3 binds the MAP kinase JNK3α2 via multiple sites on both domains.
Zhan X, Perez A, Gimenez LE, Vishnivetskiy SA, Gurevich VV.
Cell Signal 26(4):766-76. doi: 10.1016/j.cellsig.2014.01.001. Epub 2014 Jan 8. 2014
3ARR3, MAP2K4, MAP2K7, MAP3K5, MAPK10
JNK3 enzyme binding to arrestin-3 differentially affects the recruitment of upstream mitogen-activated protein (MAP) kinase kinases.
Zhan X, Kaoud TS, Kook S, Dalby KN, Gurevich VV.
J Biol Chem 288(40):28535-47. doi: 10.1074/jbc.M113.508085. Epub 2013 Aug 19. 2013
4ARR3, MAPK10
Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
Seo J, Tsakem EL, Breitman M, Gurevich VV.
J Biol Chem 286(32):27894-901. Epub 2011 Jun 29. 2011
5MAPK10
Nonvisual arrestins function as simple scaffolds assembling the MKK4-JNK3α2 signaling complex.
Zhan X, Kaoud TS, Dalby KN, Gurevich VV.
Biochemistry 50(48):10520-9. Epub 2011 Nov 9. 2011
6MAPK10
JNK3 as a therapeutic target for neurodegenerative diseases.
Antoniou X, Falconi M, Di Marino D, Borsello T.
J Alzheimers Dis 24(4):633-42. Review. 2011
7MAPK10
Gene expression profile in JNK3 null mice: a novel specific activation of the PI3K/AKT pathway.
Junyent F, de Lemos L, Verdaguer E, Folch J, Ferrer I, Ortuño-Sahagún D, Beas-Zárate C, Romero R, Pallàs M, Auladell C, Camins A.
J Neurochem 117(2):244-52. doi: 10.1111/j.1471-4159.2011.07195.x. Epub 2011 Feb 24. 2011
8ARR3, MAPK10
Identification of arrestin-3-specific residues necessary for JNK3 kinase activation.
Seo J, Tsakem EL, Breitman M, Gurevich VV.
J Biol Chem 286(32):27894-901. doi: 10.1074/jbc.M111.260448. Epub 2011 Jun 29. 2011
9MAPK10, MAPK9
Hippocampal c-Jun-N-terminal kinases serve as negative regulators of associative learning.
Sherrin T, Blank T, Hippel C, Rayner M, Davis RJ, Todorovic C.
J Neurosci 30(40):13348-61. 2010
10MAP2K1, MAP2K4, MAP3K5, MAPK1, MAPK10, RAF1
How does arrestin assemble MAPKs into a signaling complex?
Song X, Coffa S, Fu H, Gurevich VV.
J Biol Chem 284(1):685-95. Epub 2008 Nov 10. 2009
11DUSP16, MAPK10
SDF-1alpha stimulates JNK3 activity via eNOS-dependent nitrosylation of MKP7 to enhance endothelial migration.
Pi X, Wu Y, Ferguson JE 3rd, Portbury AL, Patterson C.
Proc Natl Acad Sci U S A 106(14):5675-80. Epub 2009 Mar 23.PMID: 19307591 2009
12MAPK10
Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.
Morfini GA, You YM, Pollema SL, Kaminska A, Liu K, Yoshioka K, Björkblom B, Coffey ET, Bagnato C, Han D, Huang CF, Banker G, Pigino G, Brady ST.
Nat Neurosci 12(7):864-71. Epub 2009 Jun 14. 2009
13MAPK10
JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis.
Sury MD, Agarinis C, Widmer HR, Leib SL, Christen S.
Neurobiol Dis 32(1):142-50. Epub 2008 Jul 18. 2008
14MAPK10
Cone arrestin binding to JNK3 and Mdm2: conformational preference and localization of interaction sites.
Song X, Gurevich EV, Gurevich VV.
J Neurochem 103(3):1053-62. Epub 2007 Aug 6. 2007
15CERS1, CERS2, CERS3, CERS4, CERS5, CERS6, MAPK10
JNK3 signaling pathway activates ceramide synthase leading to mitochondrial dysfunction.
Yu J, Novgorodov SA, Chudakova D, Zhu H, Bielawska A, Bielawski J, Obeid LM, Kindy MS, Gudz TI.
J Biol Chem 282(35):25940-9. Epub 2007 Jul 3. 2007
16MAPK10
Truncation of the CNS-expressed JNK3 in a patient with a severe developmental epileptic encephalopathy.
Shoichet SA, Duprez L, Hagens O, Waetzig V, Menzel C, Herdegen T, Schweiger S, Dan B, Vamos E, Ropers HH, Kalscheuer VM.
Hum Genet 118(5):559-67. Epub 2005 Oct 25. 2006
17RP1, MAPK8, MAPK9, MAPK10, MAP2K4 , MAP2, JUN
Distinct gene expression profiles and reduced JNK signaling in retinitis pigmentosa caused by RP1 mutations.
Liu J, Huang Q, Higdon J, Liu W, Xie T, Yamashita T, Cheon K, Cheng C, Zuo J.
Hum Mol Genet 14(19):2945-58. Epub 2005 Aug 26. 2005
18DUSP16, MAPK10
Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein beta-arrestin 2.
Willoughby EA, Collins MK.
J Biol Chem 280(27):25651-8. Epub 2005 May 10.PMID: 15888437 2005
19MAPK10
A critical role of neural-specific JNK3 for ischemic apoptosis.
Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, Rakic P.
Proc Natl Acad Sci U S A 100(25):15184-9. Epub 2003 Dec 01. 2003
20ABLIM1, COX7B, DYNC1I1, ITGB1BP1, IDI1, ILVBL, KIAA0494, LCMT1, MADD, MAPK10, NAT8, NR1I3, RSL1D1, DDX23, RAB2A, RARS, RNF10, TRIM24, TRPV2
High-throughput imaging of brain gene expression.
Brown VM, Ossadtchi A, Khan AH, Cherry SR, Leahy RM, Smith DJ.
Genome Res 12(2):244-54. 2002
21PTPN13, MAPK10
Head-to-head juxtaposition of Fas-associated phosphatase-1 (FAP-1) and c-Jun NH2-terminal kinase 3 (JNK3) genes: genomic structure and seven polymorphisms of the FAP-1 gene.
Yoshida S, Harada H, Nagai H, Fukino K, Teramoto A, Emi M.
J Hum Genet 47(11):614-9. 2002
22MAPK10
The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors.
Yoshida S, Fukino K, Harada H, Nagai H, Imoto I, Inazawa J, Takahashi H, Teramoto A, Emi M.
J Hum Genet 46(4):182-7. 2001